Dr. West is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 Fourth St
Stop 9400
Lubbock, TX 79430Phone+1 806-743-1842
Education & Training
- Texas Tech University Health Sciences Center at LubbockResidency, Dermatology, 2013 - 2016
- University of Kansas (Wichita)Residency, Radiology-Diagnostic, 2010 - 2011
- University of Kansas (Wichita)Internship, Internal Medicine, 2009 - 2010
- University of Kansas School of MedicineClass of 2009
Certifications & Licensure
- TX State Medical License 2022 - 2026
- KS State Medical License 2016 - 2025
- MN State Medical License 2016 - 2025
- NM State Medical License 2012 - 2013
- NC State Medical License 2011 - 2012
- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatopathology
- National Board of Physicians and Surgeons Dermatology
Publications & Presentations
PubMed
- 105 citationsThe effect of reminder systems on patients’ adherence to treatmentSarah D. Fenerty, Cameron West, Scott A. Davis, Sebastian G. Kaplan, Steven R. Feldman
Patient Preference and Adherence. 2012-02-10 - 56 citationsIncidence, Risk Factors, and Preventative Management of Skin Cancers in Organ Transplant Recipients: A Review of Single- and Multicenter Retrospective Studies from 200...Tejaswi Mudigonda, Michelle M. Levender, Jenna L. O'Neill, Cameron West, Daniel J. Pearce
Dermatologic Surgery. 2013-03-01 - 5 citationsPhototherapy trends in dermatologyKara Luersen, Tushar S. Dabade, Cameron West, Scott A. Davis, Steven R. Feldman
The Journal of Dermatological Treatment. 2014-12-01
Press Mentions
- First Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02, an Advanced Cancer Drug from Genzada Pharmaceuticals, at HonorHealth Research InstituteMarch 20th, 2019
- First-in-Human Trial Launched for Super-Enhancer Inhibitor GZ17-6.02November 25th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: